文献速递精神分裂症与精神病性障碍

基于脑功能连接的首发未用药精神分裂症治疗反应预测与个体化识别

Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity.
PubMed 文献 · Mol Psychiatry · 2018-06-19

本研究利用机器学习算法和颞上回皮层功能连接,在个体水平上识别首发未用药精神分裂症患者(准确率78.6%)并预测其对抗精神病药物治疗的反应(准确率82.5%)。研究发现互信息功能连接和相关性功能连接分别有助于识别患者和预测治疗反应,为个体化识别和治疗反应预测提供了关键步骤。

要点

  • 基于颞上回皮层功能连接的机器学习可个体化识别首发未用药精神分裂症,准确率78.6%。
  • 该功能连接特征可个体化预测抗精神病药物治疗反应,准确率82.5%。
  • 互信息功能连接和相关性功能连接分别对识别患者和预测治疗反应有信息价值。

核心结论

  • 利用颞上回皮层功能连接和机器学习可在个体水平识别首发未用药精神分裂症并预测抗精神病药物治疗反应。

研究设计与样本

  • 研究采用机器学习算法,基于静息态功能磁共振成像获取的颞上回皮层与其他皮层区域血氧水平依赖信号间的功能连接进行分析。

主要发现

  • 识别首发未用药精神分裂症患者的准确率为78.6%,预测抗精神病药物治疗反应的准确率为82.5%。
  • 互信息功能连接对识别个体首发未用药精神分裂症有信息价值,相关性功能连接对预测治疗反应有信息价值。

关键数值与推荐

  • 识别首发未用药精神分裂症的准确率为78.6%,预测治疗反应的准确率为82.5%。

临床怎么用

  • 该方法可为首发未用药精神分裂症的个体化识别和治疗反应预测提供参考,并可能补充其他生物标志物以推动精准医学发展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Identifying biomarkers in schizophrenia during the first episode without the confounding effects of treatment has been challenging. Leveraging these biomarkers to establish diagnosis and make individualized predictions of future treatment responses to antipsychotics would be of great value, but there has been limited progress. In this study, by using machine learning algorithms and the functional connections of the superior temporal cortex, we successfully identified the first-episode drug-naive (FEDN) schizophrenia patients (accuracy 78.6%) and predict their responses to antipsychotic treatment (accuracy 82.5%) at an individual level. The functional connections (FC) were derived using the mutual information and the correlations, between the blood-oxygen-level dependent signals of the superior temporal cortex and other cortical regions acquired with the resting-state functional magnetic resonance imaging. We also found that the mutual information and correlation FC was informative in identifying individual FEDN schizophrenia and prediction of treatment response, respectively. The methods and findings in this paper could provide a critical step toward individualized identification and treatment response prediction in first-episode drug-naive schizophrenia, which could complement other biomarkers in the development of precision medicine approaches for this severe mental disorder.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cao B, Cho RY, Chen D, et al. Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity. Mol Psychiatry. 2018. PMID: 29921920. doi:10.1038/s41380-018-0106-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。